Table 2.

Adverse effects. Numbers for both initial cohort (n = 88, including three patients who refused further participation) and final cohort (n = 85) are shown

Adverse effect	N (%) of patients, N = 88	N (%) of patients, N = 85
Muscle pain	4 (4.5%)	2 (2.3%)
Abdominal adverse effects (incl. liver enzyme ↑)	4 (4.5%)	1 (1.1%)
Dizziness	2 (2.3%)	2 (2.3%)
Joint pain	1 (1.1%)	1 (1.1%)

Reason for consent withdrawal in these three patients was adverse effects. Two patients had both muscle pain and abdominal adverse effects